Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments

Vaccine
J M van der VaartB J W van Klinken

Abstract

Apart from the use of oral rehydration solution, there are currently no treatment modalities for rotavirus induced diarrhoea, which is particularly relevant to developing countries. Fragments derived from llama heavy chain antibodies were previously shown to be highly stable, efficiently produced in yeast and exhibiting high epitope specific affinity. We now aim to demonstrate that these antibody fragments are capable of reducing morbidity of rotavirus induced diarrhoea. Here we show the isolation of rotavirus specific antibody fragments and their capability of reducing the morbidity of rotavirus induced diarrhoea in vivo in mice. They could provide a treatment modality for the moderation of human rotavirus infections having a significant impact on the course of an often fatal childhood disease.

Citations

Aug 21, 2007·Applied Microbiology and Biotechnology·M M Harmsen, H J De Haard
Jun 17, 2009·Medical Microbiology and Immunology·Janusz WesolowskiFriedrich Koch-Nolte
Jun 11, 2011·Microbial Cell Factories·Ario de Marco
Nov 10, 2013·International Journal of Nanomedicine·Christina G Siontorou
Oct 1, 2014·Critical Reviews in Microbiology·Zenas Kuate Defo, Byong Lee
Jan 20, 2011·Immunological Investigations·Fatemeh RahbarizadehZahra Sharifzadeh
Feb 24, 2016·Toxicon : Official Journal of the International Society on Toxinology·Robert Alvin Bernedo-Navarro, Tomomasa Yano
Dec 15, 2015·Revista Argentina de microbiología·Lucia MaffeyLorena Garaicoechea
Aug 27, 2013·Gastroenterology·Gagandeep Kang
Jul 1, 2010·Drug Discovery Today. Technologies
Dec 17, 2009·Vaccine·Peter Lachmann
Apr 16, 2016·Drug Discovery Today·Sophie SteelandClaude Libert
Apr 29, 2015·The Veterinary Quarterly·Kuldeep DhamaRaj Kumar Singh
Aug 22, 2012·Human Vaccines & Immunotherapeutics·Justyna BazanAndrzej Gamian
Jul 13, 2014·Virus Research·Ulrich Desselberger
Sep 24, 2011·Antiviral Research·Peter VanlandschootXavier Saelens
Apr 9, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Leila Safaee ArdekaniHamed Zare
Aug 13, 2015·PloS One·Lorena GaraicoecheaViviana Parreño
Aug 12, 2008·Current Opinion in Pharmacology·Dirk SaerensSerge Muyldermans
Aug 25, 2016·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Hiroshi NakayamaYuji Ito
Sep 30, 2016·Journal of Biomedical Science·Leili Aghebati-MalekiJafar Majidi
Sep 8, 2016·PloS One·Lucía MaffeyViviana Parreño
Jan 1, 2018·Pediatrics International : Official Journal of the Japan Pediatric Society·Daisuke Tokuhara
Dec 26, 2017·Frontiers in Immunology·Roghaye ArezumandSerge Muyldermans
Oct 16, 2015·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Hiroshi Kiyono, Tatsuhiko Azegami
Jan 13, 2018·Frontiers in Immunology·Yanling WuTianlei Ying
Jan 8, 2019·Reviews in Medical Virology·Atefeh AfchangiZabihollah Shoja
Jul 10, 2013·The Journal of Biological Chemistry·Christophe BlanchetotMartine J Smit
Aug 9, 2013·The Journal of Clinical Investigation·Daisuke TokuharaYoshikazu Yuki
Sep 24, 2019·Antibodies·Dorien De VliegerXavier Saelens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.